Search Results 41-50 of 17327 for egfr
This medicine is also used with chemo medicines containing platinum before having surgery for NSCLC in patients who do not have an abnormal EGFR or ALK gene ...
... EGFR or ALK gene in patients who have not received other cancer treatments. It is also used alone to treat NSCLC that has spread, whose tumors express PD-L1 ...
Pembrolizumab injection is used alone to treat non-small cell lung cancer (NSCLC) that has spread, whose tumors express PD-L1 and do not have an abnormal EGFR ...
eGFR ≥ 60 ml/mt; Capable of providing informed consent. Exclusion Criteria: eGFR ≤ 60 ml/mt; Pregnancy. Participating Mayo Clinic locations. Study statuses ...
Has a documented diagnosis of stage III or IV (defined as 30≤ estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m² and 15 ≤eGFR <30 mL/min/1.73 ...
Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...
... (EGFR) genes in patients who have not received any treatments for cancer that has already spread to other parts of the body. This medicine is also used to ...
... (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). This medicine is also used in combination with carboplatin and pemetrexed to treat ...
... [eGFR] <30 or on dialysis). This is a multicenter randomized controlled trial with a target randomization of ~1000 patients with advanced CKD and at least ...
... EGFR- or MET-based resistance to a third-generation EGFR TKI, and potential recruitment of Fc-bearing immune cells in the anti-tumor response. The ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!